<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) constitute a robust regulatory network with post-transcriptional regulatory efficiency for almost one half of human coding genes, including oncogenes and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressors </plain></SENT>
<SENT sid="1" pm="."><plain>We determined the expression profile of 667 miRNAs in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) tissues and paired non-tumoural tissues and identified 42 differentially expressed miRNAs </plain></SENT>
<SENT sid="2" pm="."><plain>We chose miR-215, miR-375, miR-378, miR-422a and miR-135b for further validation on an independent cohort of 125 clinically characterized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and for in vitro analyses </plain></SENT>
<SENT sid="3" pm="."><plain>MiR-215, miR-375, miR-378 and miR-422a were significantly decreased, whereas miR-135b was increased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissues </plain></SENT>
<SENT sid="4" pm="."><plain>Levels of miR-215 and miR-422a correlated with clinical stage </plain></SENT>
<SENT sid="5" pm="."><plain>MiR-135b was associated with higher pre-operative serum levels of CEA and CA19-9 </plain></SENT>
<SENT sid="6" pm="."><plain>In vitro analyses showed that ectopic expression of miR-215 decreases viability and migration, increases <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and promotes cell cycle arrest in DLD-1 and HCT-116 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, overexpression of miR-375 and inhibition of miR-135b led to decreased viability </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, restoration of miR-378, miR-422a and miR-375 inhibited G1/S transition </plain></SENT>
<SENT sid="9" pm="."><plain>These findings indicate that miR-378, miR-375, miR-422a and miR-215 play an important role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressors, whereas miR-135b functions as an oncogene; both groups of miRNA contribute to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> pathogenesis </plain></SENT>
</text></document>